Fredriksson and colleagues reported that TPMs in bladder cancer, glioblastoma, low-grade glioma, and thyroid cancer was significantly associated with increased TERT expression while melanoma showed no significant association between mutation status and expression when compared with wild type TERT promoter bearing tumors [133]. The gene discussed is TERT; the disease is urinary bladder cancer.